Here are five key notes:
1. National Bank Financial issued the updated target price Nov. 10.
2. The brokerage firm has a “sector perform” rating on MFC shares.
3. In November, Royal Ban of Canada lowered MFC’s target price from $14 to $13.
4. MFC shares opened Nov. 25 trading at $13.40.
5. The company’s 12-month low is $11.14 and 12-month high is $19.90.
More articles on transactions/valuations:
Kernersville Endoscopy Center proposes new ASC
Hartford HealthCare, Constitution Surgery open new ASC — 4 insights
AtlantiCare Health Park obtains regulatory approval for building with surgery center: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
